Literature DB >> 2859425

Adjuvant CMF chemotherapy in operable breast cancer: ten years later.

G Bonadonna, A Rossi, P Valagussa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2859425     DOI： 10.1016/s0140-6736(85)91740-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Contribution of randomised controlled trials to understanding and management of early breast cancer.

Authors:  M Baum; J Houghton
Journal:  BMJ       Date:  1999-08-28

Review 2.  Prevention of ovarian damage and infertility in young female cancer patients awaiting chemotherapy--clinical approach and unsolved issues.

Authors:  Katharina Hancke; Vladimir Isachenko; Evgenia Isachenko; Jürgen M Weiss
Journal:  Support Care Cancer       Date:  2011-09-23       Impact factor: 3.603

3.  Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer.

Authors:  A M Uyterlinde; N W Schipper; J P Baak
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

Review 4.  Review of general surgery 1985.

Authors:  H Ellis
Journal:  Postgrad Med J       Date:  1986-06       Impact factor: 2.401

5.  Prognostic value of nucleolar morphometric variables in cytological breast cancer specimens.

Authors:  P J van Diest; J Mouriquand; N W Schipper; J P Baak
Journal:  J Clin Pathol       Date:  1990-02       Impact factor: 3.411

6.  Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer.

Authors:  E Tichatschek; C C Zielinski; C Müller; P Sevelda; E Kubista; K Czerwenka; J Spona; H Wolf; M M Eibl
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

7.  Viral reactivation as a cause of unexplained fever in patients with progressive metastatic breast cancer.

Authors:  S Rasoul-Rockenschaub; C C Zielinski; C Müller; E Tichatschek; T Popow-Kraupp; C Kunz
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

8.  Physical Inactivity, Adverse Body Composition, and Cardiac Function in Breast Cancer Survivors: Triple Jeopardy?

Authors:  Amy A Kirkham; Coleen Power; Edith Pituskin
Journal:  JACC CardioOncol       Date:  2022-04-19

9.  At convenience and systematic random sampling: effects on the prognostic value of nuclear area assessments in breast cancer patients.

Authors:  I Jannink; J N Bennen; J Blaauw; P J van Diest; J P Baak
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

10.  Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup.

Authors:  S Nicholson; J Richard; C Sainsbury; P Halcrow; P Kelly; B Angus; C Wright; J Henry; J R Farndon; A L Harris
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.